ANDA 90027, held by Prinston Pharmaceutical. Venlafaxine Hydrochloride.
As of Nov 21, 2026, ANDA 90027 (Venlafaxine Hydrochloride), held by Prinston Pharmaceutical, was first approved by FDA on Aug 4, 2010, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 4, 2010 | Original application | Approved | None posted |
| Venlafaxine HydrochlorideEQ 25MG BASE · tablet;oral | Venlafaxine Hydrochloride | Discontinued |
| Venlafaxine HydrochlorideEQ 37.5MG BASE · tablet;oral | Venlafaxine Hydrochloride | Discontinued |
| Venlafaxine HydrochlorideEQ 50MG BASE · tablet;oral | Venlafaxine Hydrochloride | Discontinued |
| Venlafaxine HydrochlorideEQ 75MG BASE · tablet;oral | Venlafaxine Hydrochloride | Discontinued |
| Venlafaxine HydrochlorideEQ 100MG BASE · tablet;oral | Venlafaxine Hydrochloride | Discontinued |
| Aug 18, 2023 | Supplement 16Labeling · Standard review | Approved | None posted |
| Sep 21, 2021 | Supplement 15Labeling · Standard review | Approved | None posted |
| Apr 14, 2020 | Supplement 14Labeling · Standard review | Approved | None posted |
| Jan 4, 2017 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jul 17, 2014 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jul 26, 2013 | Supplement 6Labeling · Standard review | Approved | None posted |
| Oct 16, 2012 | Supplement 4Labeling · Standard review | Approved | None posted |
| Aug 4, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters